ASSENT I-(TIMI 10C) compared the safety of several doses of TNK-tPA with rtPA for the treatment of ST elevation myocardial infarction.
PRESENTATIONS
PUBLICATIONS
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School
